These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5608897)

  • 1. [Morphologic anomalies of lymphocytes in schizophrenic patients in relation to various therapeutic methods].
    Belloni F
    Acta Neurol (Napoli); 1967; 22(5):689-700. PubMed ID: 5608897
    [No Abstract]   [Full Text] [Related]  

  • 2. A double blind controlled study of ECT vs chlorpromazine in schizophrenia.
    Bagadia VN; Abhyankar RR; Doshi J; Pradhan PV; Shah LP
    J Assoc Physicians India; 1983 Oct; 31(10):637-40. PubMed ID: 6671932
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of chronic schizophrenic patients with haloperidol and chlorpromazine combined.
    Jones B; Lehmann HE; Saxena BM; Ban TA
    Curr Ther Res Clin Exp; 1968 Jun; 10(6):276-8. PubMed ID: 4969832
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of glucose tolerance tests and changes in inorganic serum phosphate and potassium levels in schizophrenic patients responding to treatment with psychotropic drugs].
    Máthé V; Kassay G; Tüske M
    Int Pharmacopsychiatry; 1971; 6(2):111-30. PubMed ID: 4147757
    [No Abstract]   [Full Text] [Related]  

  • 5. [Late schizophrenia].
    Morishita S
    Ryoikibetsu Shokogun Shirizu; 2003; (38):80-3. PubMed ID: 12876935
    [No Abstract]   [Full Text] [Related]  

  • 6. [A therapeutic pathomorphosis of schizophrenia proceeding with paranoid disorders].
    Ozola MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(4):600-5. PubMed ID: 5497116
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in the symptomatological picture of schizophrenia in relation to the introduction of neuroleptics].
    Modrzewska K
    Psychiatr Pol; 1988; 22(5):349-55. PubMed ID: 2907659
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of psychic masochism in schizophrenic patients.
    Perlson P; Tobin JM
    Dis Nerv Syst; 1970 Nov; 31():Suppl:122-9. PubMed ID: 5489377
    [No Abstract]   [Full Text] [Related]  

  • 9. Patterns of response to amitriptyline and haloperidol among borderline patients.
    Soloff PH; George A; Nathan RS; Schulz P; Cornelius J
    Psychopharmacol Bull; 1988; 24(2):264-8. PubMed ID: 3212160
    [No Abstract]   [Full Text] [Related]  

  • 10. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atypical lymphocytes in schizophrenic patients].
    Guo QY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Jun; 19(3):185-7. PubMed ID: 3757639
    [No Abstract]   [Full Text] [Related]  

  • 12. [The properdin system in patients with schizophrenia during the process of active therapy].
    Kaz'mina SA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(1):101-5. PubMed ID: 4147791
    [No Abstract]   [Full Text] [Related]  

  • 13. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.
    Levinson I; Levine S
    Biol Psychiatry; 1995 Aug; 38(3):198-200. PubMed ID: 7578667
    [No Abstract]   [Full Text] [Related]  

  • 14. Ataractic drugs versus ECT in schizophrenia.
    Spensley J
    Am J Psychiatry; 1973 Oct; 130(10):1162-3. PubMed ID: 4728918
    [No Abstract]   [Full Text] [Related]  

  • 15. Alterations in serum amino acid concentrations in male and female schizophrenic patients.
    Tomiya M; Fukushima T; Watanabe H; Fukami G; Fujisaki M; Iyo M; Hashimoto K; Mitsuhashi S; Toyo'oka T
    Clin Chim Acta; 2007 May; 380(1-2):186-90. PubMed ID: 17367771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drawings of a schizophrenic during a Sakel cure].
    Michaux L; Gallot HM; Schneider JJ
    Ann Med Psychol (Paris); 1967 Jul; 125(2):286-90. PubMed ID: 4864794
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of treatment with an amino oxidase inhibitor on the excretion of bufotenin and the clinical symptoms in chronic schizophrenic patients.
    Heller B
    Int J Neuropsychiatry; 1966 Apr; 2(2):193-203. PubMed ID: 5959966
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative results of pharmacologic loading with aminazine and heloperidol in the treatment of the simple form of schizophrenia (according to pain sensography findings)].
    Almazov BN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(9):1397-1401. PubMed ID: 4423309
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood levels of haloperidol in schizophrenic patients.
    Shvartsburd A; Dekirmenjian H; Smith RC
    J Clin Psychopharmacol; 1983 Feb; 3(1):7-12. PubMed ID: 6833528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ECT in affective and schizophrenic illness.
    Greenblatt M
    Am J Psychiatry; 1977 Sep; 134(9):1001-5. PubMed ID: 331967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.